NCT07629687 Non-invasive Auricular Vagus Nerve Stimulation (taVNS) on Postural Control and Autonomic Responses in Stroke
| NCT ID | NCT07629687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 22 participants |
| Start Date | 2026-05-20 |
| Primary Completion | 2026-10-20 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 22 participants in total. It began in 2026-05-20 with a primary completion date of 2026-10-20.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial is conducted to determine the effects of transcutaneous auricular Vagus nerve stimulation (taVNS) on postural control in stroke patients (e.g., improvements in balance, mobility, and functional stability) and to evaluate the effects of taVNS on autonomic nervous system responses in stroke patients (e.g., changes in heart rate variability, blood pressure variability, skin conductance, and temperature).
Eligibility Criteria
Inclusion Criteria: * Age between 18 to 70years who are diagnosed with ischemic brain injury, intracerebral hemorrhage shown by magnetic resonance imaging, or computed tomography. * First occurrence of stroke characterized by a unilateral lesion, with an onset time (acute/ subacute) \< 6 months * With balance impairment (BBS Score = 21-44); * no or mild spasticity on the lower-limb assessed by Modified Ashworth Scale (MAS ≤ 2); * sufficient cognition to follow the instructions provided by the therapists and the computer. Exclusion Criteria: * Individuals exhibiting unstable vital signs, consciousness disorders, or an inability to cooperate with examination and treatment procedures * Those with a heart rate below 60 beats per minute, or with implantable devices such as pacemakers or cochlear implants. * Other medical or psychological conditions affecting participation
Contact & Investigator
Hajra Arshad, MS-NMPT*
PRINCIPAL INVESTIGATOR
Riphah International Unversity
Frequently Asked Questions
Who can join the NCT07629687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07629687 currently recruiting?
Yes, NCT07629687 is actively recruiting participants. Contact the research team at arshad.nawaz@riphah.edu.pk for enrollment information.
Where is the NCT07629687 trial being conducted?
This trial is being conducted at Islamabad, Pakistan.
Who is sponsoring the NCT07629687 clinical trial?
NCT07629687 is sponsored by Riphah International University. The principal investigator is Hajra Arshad, MS-NMPT* at Riphah International Unversity. The trial plans to enroll 22 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.